BIOMAT Database Logo BIOMAT Database Logo

Intravenous immunoglobulin for polymyositis and dermatomyositis. 1990

P Cherin, and S Herson, and B Wechsler, and J C Piette, and O Bletry, and J M Ziza, and C Degennes, and P Godeau

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009220 Myositis Inflammation of a muscle or muscle tissue. Inflammatory Myopathy,Myositis, Focal,Myositis, Infectious,Idiopathic Inflammatory Myopathies,Idiopathic Inflammatory Myopathy,Idiopathic Inflammatory Myositis,Infectious Myositis,Inflammatory Muscle Diseases,Inflammatory Myopathies, Idiopathic,Inflammatory Myopathy, Idiopathic,Muscle Diseases, Inflammatory,Myopathies, Idiopathic Inflammatory,Myopathy, Inflammatory,Myositis, Proliferative,Focal Myositides,Focal Myositis,Infectious Myositides,Inflammatory Muscle Disease,Inflammatory Myopathies,Muscle Disease, Inflammatory,Myopathies, Inflammatory,Myopathy, Idiopathic Inflammatory,Myositides,Myositides, Focal,Myositides, Infectious,Myositides, Proliferative,Proliferative Myositides,Proliferative Myositis
D003882 Dermatomyositis A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6) Polymyositis-Dermatomyositis,Dermatomyositis, Adult Type,Dermatomyositis, Childhood Type,Dermatopolymyositis,Juvenile Dermatomyositis,Juvenile Myositis,Adult Type Dermatomyositis,Childhood Type Dermatomyositis,Dermatomyositis, Juvenile,Myositis, Juvenile,Polymyositis Dermatomyositis
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005719 gamma-Globulins Serum globulins that migrate to the gamma region (most positively charged) upon ELECTROPHORESIS. At one time, gamma-globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins and conversely most gamma globulins are immunoglobulins. But since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline. gamma-Globulin,gamma Globulin,gamma Globulins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P Cherin, and S Herson, and B Wechsler, and J C Piette, and O Bletry, and J M Ziza, and C Degennes, and P Godeau
Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis.
October 2002, Current rheumatology reports,
P Cherin, and S Herson, and B Wechsler, and J C Piette, and O Bletry, and J M Ziza, and C Degennes, and P Godeau
Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis.
January 2002, Annals of the rheumatic diseases,
P Cherin, and S Herson, and B Wechsler, and J C Piette, and O Bletry, and J M Ziza, and C Degennes, and P Godeau
Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis.
January 2009, Lung,
P Cherin, and S Herson, and B Wechsler, and J C Piette, and O Bletry, and J M Ziza, and C Degennes, and P Godeau
[Intravenous immunoglobulins in polymyositis and dermatomyositis].
January 1999, La Revue de medecine interne,
P Cherin, and S Herson, and B Wechsler, and J C Piette, and O Bletry, and J M Ziza, and C Degennes, and P Godeau
Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review.
May 2012, Clinical rheumatology,
P Cherin, and S Herson, and B Wechsler, and J C Piette, and O Bletry, and J M Ziza, and C Degennes, and P Godeau
Prospective study of high-dose intravenous immunoglobulin for the treatment of steroid-resistant polymyositis and dermatomyositis.
December 2003, Modern rheumatology,
P Cherin, and S Herson, and B Wechsler, and J C Piette, and O Bletry, and J M Ziza, and C Degennes, and P Godeau
Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis.
April 2022, Rheumatology (Oxford, England),
P Cherin, and S Herson, and B Wechsler, and J C Piette, and O Bletry, and J M Ziza, and C Degennes, and P Godeau
[Immunoglobulin deposition in skeletal muscle in polymyositis and dermatomyositis].
February 1993, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
P Cherin, and S Herson, and B Wechsler, and J C Piette, and O Bletry, and J M Ziza, and C Degennes, and P Godeau
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application.
January 2011, Autoimmunity reviews,
P Cherin, and S Herson, and B Wechsler, and J C Piette, and O Bletry, and J M Ziza, and C Degennes, and P Godeau
Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis.
January 2008, Modern rheumatology,
Copied contents to your clipboard!